-
Savarirayan, R, Ireland, P, Irving, M, Thompson, D, Alves, I, Baratela, WAR, Betts, J, Bober, MB, Boero, S, Briddell, J, et al.
International Consensus Statement on the diagnosis, multidisciplinary management and lifelong care of individuals with achondroplasia.
Nature Reviews Endocrinology
18(3)
:
173 -189
2022
view publication
-
Irving, M, Hoover-Fong, J, Bacino, C, Charrow, J, Cormier-Daire, V, Polgreen, L, Harmatz, P, Dickson, P, Bober, M, Mohnike, K, et al.
OP021: Vosoritide for children with achondroplasia: Growth velocity and pubertal milestones.
Genetics in Medicine
24(3)
:
s352 -s353
2022
view publication
-
Irving, M, Savarirayan, R, Arundel, P, Polgreen, L, Mohnike, K, Ozono, K, Saunders, M, Fisheleva, E, Huntsman-Labed, A, Day, J.
eP266: Associations between height and Health-Related Quality of Life (HRQoL) and functional independence in children with achondroplasia.
Genetics in Medicine
24(3)
:
s168 -s169
2022
view publication
-
Savarirayan, R, Baratela, W, Butt, T, Cormier-Daire, V, Irving, M, Miller, B, Mohnike, K, Ozono, K, Rosenfeld, R, Selicorni, A, et al.
eP204: Expert opinions regarding impact of achondroplasia on health-related quality of life and long-term effects of vosoritide: A modified Delphi study.
Genetics in Medicine
24(3)
:
s126 -s127
2022
view publication
-
Chan, ML, Qi, Y, Larimore, K, Cherukuri, A, Seid, L, Jayaram, K, Jeha, G, Fisheleva, E, Day, J, Huntsman-Labed, A, et al.
Pharmacokinetics and Exposure–Response of Vosoritide in Children with Achondroplasia.
Clinical Pharmacokinetics
61(2)
:
263 -280
2022
view publication